Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Health

Groundbreaking Treatment Hope for Ovarian Cancer: ‘We’ll be able to actually make a vaccine to help fight that disease’

Groundbreaking Treatment Hope for Ovarian Cancer: ‘We’ll be able to actually make a vaccine to help fight that disease’

By 9News Staff, 12:22am Mar 22, 2024

When 24-year-old Tora Murphy quit her job to see the world, she never expected her travels would be cut short after just seven weeks. Murphy’s life took an unexpected turn when she was diagnosed with stage three ovarian cancer after noticing physical changes during her travels. Ovarian cancer, a disease claiming the lives of 1000 Australian women every year with a five-year survival rate of 49%, has been a daunting reality for many.

Murphy’s journey led to surgery to remove an 18-centimeter tumor and a full hysterectomy. Reflecting on her experience, she expressed disbelief at the diagnosis, stating, ‘I didn’t even know that people like me could get cancer.’ The emotional toll of the disease is evident as she shared her concerns about the potential of recurrence, acknowledging that it may forever loom over her.

However, there is new hope on the horizon. Mater Research scientists have embarked on groundbreaking work, targeting molecules on a key immune system trigger, dendritic cells. Professor Kristen Radford from Mater Research expressed optimism about the potential of their work, stating, ‘We think that by focusing on that cell type in particular, that we’ll be able to actually make a vaccine to help fight that disease and to eventually help prevent recurrence.’

The development of this vaccine is made possible by $670,000 in funding raised by the Ovarian Cancer Research Foundation, part of a larger $2.4 million in grants. Georgie Herbert from the foundation highlighted the community’s contribution, emphasizing that the funds were raised through various activities such as walking, running, baking, and shaving heads.

Murphy’s story has also inspired fundraising efforts, with her partner and friends planning a 100-kilometer walk in May to support the cause. She expressed gratitude, emphasizing the impact of such initiatives, stating, ‘Their money goes to such a good place.’

The groundbreaking research and fundraising efforts offer a glimmer of hope for those affected by ovarian cancer. The potential of a vaccine to combat the disease and prevent recurrence signifies a significant stride in the battle against this formidable illness.

For more news and updates, visit leximural.com

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *